Baxter (BAX) gains on a slew of regulatory approvals and strategic collaborations.
Baxter (BAX) steadily focuses on improving its Advanced Surgery business.
Recent buyouts and positive regulatory tidings boost investors' confidence on Baxter International (BAX).
Mallinckrodt (MNK) shares gained as the company beat both earnings and revenue estimates in the fourth quarter as Inomax sales revived somewhat.
Strong performance in the Hospital Products and Renal Products segments drives Baxter (BAX) in Q4.
Baxter International Inc. (BAX) reports solid Q4 performance on the back of strong segmental growth.
As part of the amended tax policy, corporate tax rates are lowered to 21% from 35%, offering a huge relief to medical device giants.
Baxter International (BAX) is expected to gain from strength in Hospital Products segment on solid sales in the U.S. Fluid Systems business as well as growing demand for injectable pharmaceuticals.
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
PerkinElmer (PKI) solid product portfolio, positive market trends and acquisition are likely to drive earnings in the fourth quarter.
Baxter's (BAX) Arisure Closed System reduces exposure risk of healthcare professionals to needles. Also, the latest development promotes safe handling of hazardous drugs.
Baxter International разослала зараженную вакцину от гриппа - ВОЙНА и МИРИнформационно-аналитический ресурс о событиях в мире: текущие новости, еженедельные обзоры, обсуждения. Posted by Oleg Nasobin on 30 дек 2017, 08:10
Illumina (ILMN) harbors hopes about recent launches like NovaSeq S4 flow cell and reagent kit for its NovaSeq 6000 System. A low margin scenario due to the NovaSeq launch is a concern.
PRA Health (PRAH) touches 52-week high on consistent revenue performance and Symphony Health integration.
Zimmer Biomet (ZBH) fights challenges like supply delay of certain products that curb its capacity to regain lost US-based customers and net in the new ones.
Baxter (BAX) has been gaining on the back of favorable developments in the regulatory front and product launches.
Zacks.com highlights: Lululemon Athletica, Chemed, Baxter International, NVR and Copart
We have considered four popular ratios in order to find efficient companies that have the potential to provide impressive returns